Julie Rubinstein Adaptive Biotechnologies Corp (ADPT) insider trading activity

Julie Rubinstein is President of Adaptive Biotechnologies Corp. Currently has a direct ownership of 472,754 shares of ADPT, which is worth approximately $2.37 Million. The most recent transaction as insider was on Mar 05, 2024, when has been sold 39,070 shares (Common Stock) at a price of $3.5 per share, resulting in proceeds of $136,745. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 473K

0% 3M change

40.36% 12M change

Total Value Held $2.37 Million

JULIE RUBINSTEIN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 05 2024	SELL Open market or private sale	$136,745 $3.5 p/Share	39,070 Reduced 7.63%	472,754 Common Stock
Mar 04 2024	BUY Grant, award, or other acquisition	-	175,000 Added 25.48%	511,824 Common Stock
Mar 06 2023	SELL Open market or private sale	$194,264 $8.57 p/Share	22,668 Reduced 6.31%	336,824 Common Stock
Mar 06 2023	BUY Grant, award, or other acquisition	-	132,979 Added 27.0%	359,492 Common Stock
Mar 07 2022	SELL Open market or private sale	$55,402 $12.01 p/Share	4,613 Reduced 2.0%	226,513 Common Stock
Mar 04 2022	BUY Grant, award, or other acquisition	-	185,338 Added 44.5%	231,126 Common Stock
Mar 04 2021	BUY Grant, award, or other acquisition	-	45,788 Added 50.0%	45,788 Common Stock
Mar 01 2021	SELL Open market or private sale	$875,850 $58.39 p/Share	15,000 Reduced 100.0%	0 Common Stock
Mar 01 2021	BUY Exercise of conversion of derivative security	$98,250 $6.55 p/Share	15,000 Added 50.0%	15,000 Common Stock
Feb 26 2021	SELL Open market or private sale	$843,450 $56.23 p/Share	15,000 Reduced 100.0%	0 Common Stock
Feb 26 2021	BUY Exercise of conversion of derivative security	$98,250 $6.55 p/Share	15,000 Added 50.0%	15,000 Common Stock
Feb 25 2021	SELL Open market or private sale	$832,513 $56.73 p/Share	14,675 Reduced 100.0%	0 Common Stock
Feb 25 2021	BUY Exercise of conversion of derivative security	$96,121 $6.55 p/Share	14,675 Added 50.0%	14,675 Common Stock
Feb 24 2021	SELL Open market or private sale	$868,650 $57.91 p/Share	15,000 Reduced 100.0%	0 Common Stock
Feb 24 2021	BUY Exercise of conversion of derivative security	$98,250 $6.55 p/Share	15,000 Added 50.0%	15,000 Common Stock
Feb 23 2021	SELL Open market or private sale	$828,750 $55.25 p/Share	15,000 Reduced 100.0%	0 Common Stock
Feb 23 2021	BUY Exercise of conversion of derivative security	$98,250 $6.55 p/Share	15,000 Added 50.0%	15,000 Common Stock
Feb 22 2021	SELL Open market or private sale	$910,050 $60.67 p/Share	15,000 Reduced 100.0%	0 Common Stock
Feb 22 2021	BUY Exercise of conversion of derivative security	$98,250 $6.55 p/Share	15,000 Added 50.0%	15,000 Common Stock
Feb 19 2021	SELL Open market or private sale	$934,050 $62.27 p/Share	15,000 Reduced 100.0%	0 Common Stock
Feb 19 2021	BUY Exercise of conversion of derivative security	$98,250 $6.55 p/Share	15,000 Added 50.0%	15,000 Common Stock
Feb 18 2021	SELL Open market or private sale	$912,750 $60.85 p/Share	15,000 Reduced 100.0%	0 Common Stock
Feb 18 2021	BUY Exercise of conversion of derivative security	$98,250 $6.55 p/Share	15,000 Added 50.0%	15,000 Common Stock
Feb 17 2021	SELL Open market or private sale	$929,400 $61.96 p/Share	15,000 Reduced 100.0%	0 Common Stock
Feb 17 2021	BUY Exercise of conversion of derivative security	$98,250 $6.55 p/Share	15,000 Added 50.0%	15,000 Common Stock

Julie Rubinstein

President

Seattle, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADPT shares.

Notify only if

Value

Insider Trading

Get notified when an Adaptive Biotechnologies Corp insider buys or sells ADPT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Adaptive Biotechnologies Corp

Track Activities on ADPT

Account